Ismail, Zahinoor http://orcid.org/0000-0002-5529-3731
Creese, Byron http://orcid.org/0000-0001-6490-6037
Aarsland, Dag
Kales, Helen C.
Lyketsos, Constantine G.
Sweet, Robert A. http://orcid.org/0000-0001-9154-9709
Ballard, Clive http://orcid.org/0000-0003-0022-5632
Article History
Accepted: 29 November 2021
First Online: 4 January 2022
Competing interests
: Z.I. has received research funding from Canadian Institutes of Health Research and Brain Canada, and has received personal fees from Lundbeck and Otsuka not related to the submitted work. His institution has received fees from Acadia, Biogen, Roche and Sunovion. D.A. has received research support and/or honoraria from AstraZeneca, H. Lundbeck, Novartis Pharmaceuticals, and GE Health and serves as a paid consultant for H. Lundbeck, Eisai and Axovant. C.G.L. has received grant support (research or Continuing Medical Education) from the National Institute of Mental Health, the National Institute on Aging, the Associated Jewish Federation of Baltimore, the Weinberg Foundation, Forest, GlaxoSmithKline, Eisai, Pfizer, AstraZeneca, Lilly, Ortho-McNeil, Bristol Myers Squibb, Novartis, the National Football League (NFL), Elan, Functional Neuromodulation and Bright Focus Foundation; received payment as a consultant or adviser from AstraZeneca, GlaxoSmithKline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck, Merz, Lilly, Pfizer, Genentech, Elan, NFL Players Association, NFL Benefits Office, Avanir, Zinfandel, BMS, AbbVie, Janssen, Orion, Otsuka, Servier and Astellas, and received honoraria or travel support from Pfizer, Forest, GlaxoSmithKline, and Health Monitor. Clive Ballard has received grants and personal fees from Acadia and Lundbeck, and personal fees from Heptares, Roche, Lilly, Otsuka, Orion, GlaxoSmithKline and Pfizer. B.C., H.C.K. and R.A.S. declare no competing interests.
Free to read: This content has been made available to all.